Brucellosis secondary prevention: Difference between revisions

Jump to navigation Jump to search
m (Changes made per Mahshid's request)
m (Bot: Removing from Primary care)
 
(One intermediate revision by one other user not shown)
Line 11: Line 11:


{{reflist|2}}
{{reflist|2}}
[[Category:Disease]]
{{WH}}
[[Category:Primary care]]
{{WS}}
[[Category:Up-To-Date]]


[[Category:Pulmonology]]  
[[Category:Disease]]
[[Category:Up-To-Date]]
[[Category:Pulmonology]]
[[Category:Hepatology]]
[[Category:Hepatology]]
[[Category:Rheumatology]]
[[Category:Rheumatology]]
[[Category:Nephrology]]
[[Category:Nephrology]]
 
[[Category:Emergency medicine]]
{{WH}}
[[Category:Infectious disease]]
{{WS}}

Latest revision as of 20:45, 29 July 2020

Brucellosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Brucellosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Principles of diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X-Ray

CT Scan

MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Brucellosis secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Brucellosis secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Brucellosis secondary prevention

CDC on Brucellosis secondary prevention

Brucellosis secondary prevention in the news

Blogs on Brucellosis secondary prevention

Directions to Hospitals Treating Brucellosis

Risk calculators and risk factors for Brucellosis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1],Associate Editor(s)-in-Chief: Vishal Devarkonda, M.B.B.S[2]

Overview

Secondary prevention strategies of Brucellosis include follow up of the patient upto 2 years following the diagnosis of Brucellosis to monitor for relapse.

Secondary prevention

Secondary prevention strategies of Brucellosis include follow up of the patient upto 2 years following the diagnosis of Brucellosis to monitor for relapse and chronic brucellosis.[1]

Reference

  1. Brucellosis "Dennis Kasper, Anthony Fauci, Stephen Hauser, Dan Longo, J. Larry Jameson, Joseph Loscalzo"Harrison's Principles of Internal Medicine, 19e Accessed on December 9th, 2017

Template:WH Template:WS